Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
12.80
-0.01 (-0.08%)
At close: Jun 18, 2025, 4:00 PM
13.58
+0.78 (6.09%)
Pre-market: Jun 20, 2025, 7:44 AM EDT
Company Description
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Liminatus Pharma, Inc.
| Country | United States |
| Founded | 2018 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Chris Kim |
Contact Details
Address: 6 Centerpointe Drive, #625 La Palma, California 90623 United States | |
| Website | liminatuspharma.com |
Stock Details
| Ticker Symbol | LIMN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001831874 |
| ISIN Number | US53271X1081 |
Key Executives
| Name | Position |
|---|---|
| Chris Kim J.D., L.L.M. | Chief Executive Officer, Treasurer and Secretary |